Zocor

A Key Vytorin Memo Was Misleading And Inaccurate

10 Comments

FDA’s Woodcock: Vytorin Data Speaks For Itself

4 Comments

Did The ENHANCE Trial Enhance Anything?

10 Comments

The Vytorin Saga Continues: Krumholz Strikes Back

8 Comments

Will Insurers Reduce Coverage For Vytorin?

2 Comments

Schering-Plough CEO Implies Vytorin Critic Is Biased

20 Comments

Vytorin Fallout: DTC Ads, Dear Doc Letters And…

5 Comments

Secret Vytorin E-Mails Show Kastelein’s Fury

19 Comments

AstraZeneca Halts Crestor Trial Due To…

6 Comments

ENHANCE Doesn’t Enhance Our Knowledge Much

3 Comments

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/

-->